First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer

Clinical trial NCT07529717 · RECRUITING

Trial details

NCT number: NCT07529717
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Prostate Cancer

Start date: 2026-05-18
Primary completion: 2027-11-17
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.